LEADER 01215nam0-2200409---450- 001 990006071020403321 005 20110705091345.0 035 $a000607102 035 $aFED01000607102 035 $a(Aleph)000607102FED01 035 $a000607102 100 $a20110705d1990----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $ay---n---001yy 200 1 $a<>straniero nel diritto italiano$eappendice di aggiornamento$ele nuove norme sull'ingresso, soggiorno e asilo$fBruno Nascimbene 210 $aMilano$cGiuffrè$d1990 215 $avi, 94 p.$d24 cm 225 1 $a<>Italia e la vita giuridica internazionale$v2 300 $aRistampa integrata 676 $a342.450 83$v19$zita 700 1$aNascimbene,$bBruno$0129417 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990006071020403321 952 $aX O 130 (2)$b11855*$fFGBC 952 $aX O 130 (2bis)$b7498*$fFGBC 952 $aXXVI 516(2) CC$b1550$fDDCIC 952 $aH 68$bs.i.$fDSI 952 $aH 68$bs.i.$fDSI 952 $aDI 5/c-7$b8809$fDEC 959 $aDDCIC 959 $aDSI 959 $aFGBC 959 $aDEC 996 $aStraniero nel diritto italiano$962378 997 $aUNINA LEADER 04667nam 2200625 a 450 001 9910457825703321 005 20200520144314.0 010 $a1-283-31755-9 010 $a9786613317551 010 $a1-61705-019-9 035 $a(CKB)2550000000063677 035 $a(EBL)787865 035 $a(OCoLC)758334168 035 $a(SSID)ssj0000539475 035 $a(PQKBManifestationID)12232431 035 $a(PQKBTitleCode)TC0000539475 035 $a(PQKBWorkID)10585211 035 $a(PQKB)11297638 035 $a(MiAaPQ)EBC787865 035 $a(Au-PeEL)EBL787865 035 $a(CaPaEBR)ebr10509680 035 $a(CaONFJC)MIL331755 035 $a(EXLCZ)992550000000063677 100 $a20110608d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aNeurologic complications of cancer therapy$b[electronic resource] /$f[edited by] Patrick Y. Wen, David Schiff, Eudocia C. Quant 210 $aNew York $cdemos Medical$dc2012 215 $a1 online resource (439 p.) 300 $aDescription based upon print version of record. 311 $a1-936287-07-2 320 $aIncludes bibliographical references and index. 327 $aNeurologic complications of alkylating agent chemotherapy / Herbert B. Newton -- Neurologic complications of antimetabolites / Ryan Merrell, Jorg Dietrich, and Tracy Batchelor -- Neurologic complications associated with plant alkaloids / Abhishek Singla, Aditya Bardia, and Vinay Chaudhry -- Neurologic complications of topoisomerase inhibitors / April F. Eichler -- Neurologic complications of epothilones and amino acid degraders / April F. Eichler -- Neurologic complications of corticosteroids / Erin M Dunbar, Rizwan Kalani, and Santosh Kesari -- Neurologic complications of immunomodulatory agents / Stuart C. Apfel -- Neurologic complications of immunosuppressive drugs / Ramani Balu and Amy A.Pruitt -- Neurologic complications associated with biologic agents / Aaron G. Mammoser and Morris D. Groves -- Neurologic complications of targeted therapy / Eudocia C. Quant ... [et al.] -- Neurologic complications of hormonal chemotherapies / Wendy Sherman Sojka and Jeffrey Raizer -- Neurologic complications associated with supportive therapies / Jan Drappatz -- Chemotherapy-associated cognitive dysfunction / Jorg Dietrich and Alexander Pine -- Central nervous system toxicity of chemotherapy / Jerome J. Graber and Lisa M. DeAngelis -- Neurologic complications affecting peripheral nerves / Guido Cavaletti and Paola Marmiroli -- Neurologic complications affecting muscles and the neuromuscular junction / Kelly G. Gwathmey, Ted M. Burns, and Elliot L. Dimberg -- Cellular mechanisms of radiation injury to cognition / Michelle Monje -- Central nervous system complications of radiation therapy / Damien Ricard ... [et al.] -- Radiation-induced tumors / Hilary L. Somerset, B.K. Kleinschmidt-DeMasters, and Kevin O. Lillehei -- Radiation vasculopathy / Lisa R. Rogers -- Radiation myelopathy / Timothy E. Schultheiss -- Radiation-induced peripheral nerve disorders / Odysseas Kargiotis and Athanasios P. Kyritsis -- Complications of neurosurgical oncology / Brian J. Williams, Robert G. Louis, and Mark E. Shaffrey -- Neurologic complications of hematopoietic stem cell transplantation / Eudocia C. Quant and Patrick Y. Wen. 330 $aNeurologic side effects of cancer therapy can inhibit treatment, can be dose-limiting and can diminish quality-of-life. Neurotoxicity related to cancer therapy is a common problem in oncology practice and in clinical neurology. Recognition of neurologic complications of anticancer therapy is necessary due to potential confusion with metastatic disease, paraneoplastic syndromes or comorbid neurologic disorders that do not require reduction or discontinuation of therapy. Neurologic Complications of Cancer Therapy provides comprehensive coverage of the recognition and management of neurologic sym 606 $aCancer$xTreatment$xComplications 606 $aCancer$xTreatment 606 $aNeurologic manifestations of general diseases 608 $aElectronic books. 615 0$aCancer$xTreatment$xComplications. 615 0$aCancer$xTreatment. 615 0$aNeurologic manifestations of general diseases. 676 $a616.99/406 701 $aWen$b Patrick Y$01051379 701 $aSchiff$b David$f1959-$0967491 701 $aLee$b Eudocia Quant$01051380 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910457825703321 996 $aNeurologic complications of cancer therapy$92481852 997 $aUNINA